Literature DB >> 29926471

The challenges of 'medical cannabis' and mental health: a clinical perspective.

Giles Newton-Howes1.   

Abstract

The use of cannabis as a medicine has a long tradition in Western medicine. It has been seen as a viable option for the treatment of various neurological and psychiatric conditions, and recently there is again interest in the place of cannabinoids in the pharmacopoeia. What has become increasingly clear, however, is these benefits need to be weighed carefully against the potential difficulty associated with herbal cannabis and cannabinoid compounds for an individual's mental health. This challenges the use of cannabis as a medication and the regulation of its prescription.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  cannabis; marijuana; mental health; risks

Mesh:

Substances:

Year:  2018        PMID: 29926471      PMCID: PMC6177706          DOI: 10.1111/bcp.13687

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Do medical marijuana laws increase marijuana use? Replication study and extension.

Authors:  Sam Harper; Erin C Strumpf; Jay S Kaufman
Journal:  Ann Epidemiol       Date:  2012-01-29       Impact factor: 3.797

2.  Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win.

Authors:  Carla J Berg; Erin Stratton; Gillian L Schauer; Michael Lewis; Yanwen Wang; Michael Windle; Michelle Kegler
Journal:  Subst Use Misuse       Date:  2014-09-30       Impact factor: 2.164

Review 3.  The challenges of 'medical cannabis' and mental health: a clinical perspective.

Authors:  Giles Newton-Howes
Journal:  Br J Clin Pharmacol       Date:  2018-07-19       Impact factor: 4.335

4.  Tests of causal linkages between cannabis use and psychotic symptoms.

Authors:  David M Fergusson; L John Horwood; Elizabeth M Ridder
Journal:  Addiction       Date:  2005-03       Impact factor: 6.526

5.  Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence.

Authors:  Magdalena Cerdá; Melanie Wall; Katherine M Keyes; Sandro Galea; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2011-11-17       Impact factor: 4.492

6.  Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.

Authors:  Antti Mustonen; Solja Niemelä; Tanja Nordström; Graham K Murray; Pirjo Mäki; Erika Jääskeläinen; Jouko Miettunen
Journal:  Br J Psychiatry       Date:  2018-04       Impact factor: 9.319

7.  New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users.

Authors:  Megan Pledger; Greg Martin; Jacqueline Cumming
Journal:  N Z Med J       Date:  2016-04-22

8.  Cannabis use and mental health in young people: cohort study.

Authors:  George C Patton; Carolyn Coffey; John B Carlin; Louisa Degenhardt; Michael Lynskey; Wayne Hall
Journal:  BMJ       Date:  2002-11-23

9.  Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013.

Authors:  Deborah S Hasin; Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Bridget F Grant
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

Review 10.  Cannabidiol as a Potential Treatment for Anxiety Disorders.

Authors:  Esther M Blessing; Maria M Steenkamp; Jorge Manzanares; Charles R Marmar
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

View more
  2 in total

1.  Clinical trial simulations of the interaction between cannabidiol and clobazam and effect on drop-seizure frequency.

Authors:  Kirsten Riber Bergmann; Karen Broekhuizen; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2019-12-12       Impact factor: 4.335

Review 2.  The challenges of 'medical cannabis' and mental health: a clinical perspective.

Authors:  Giles Newton-Howes
Journal:  Br J Clin Pharmacol       Date:  2018-07-19       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.